Literature DB >> 16326715

NMR solution structure of the tandem Src homology 3 domains of p47phox complexed with a p22phox-derived proline-rich peptide.

Kenji Ogura1, Ikuo Nobuhisa, Satoru Yuzawa, Ryu Takeya, Shinnosuke Torikai, Kazuya Saikawa, Hideki Sumimoto, Fuyuhiko Inagaki.   

Abstract

The phagocyte NADPH oxidase plays a crucial role in host defense against microbial infections by generating reactive oxygen species. It is a multisubunit enzyme composed of membrane-bound flavocytochrome b558 as well as cytosolic components, including p47phox, which is essential for assembly of the complex. When phagocytes are activated, the cytosolic components of the NADPH oxidase translocate to flavocytochrome b558 due to binding of the tandem Src homology 3 (SH3) domains of p47phox to a proline-rich region in p22phox, a subunit of flavocytochrome b558. Using NMR titration, we first identified the proline-rich region of p22phox that is essential for binding to the tandem SH3 domains of p47phox. We subsequently determined the solution structure of the p47phox tandem SH3 domains complexed with the proline-rich peptide of p22phox using NMR spectroscopy. In contrast to the intertwined dimer reported for the crystal state, the solution structure is a monomer. The central region of the p22phox peptide forms a polyproline type II helix that is sandwiched by the N- and C-terminal SH3 domains, as was observed in the crystal structure, whereas the C-terminal region of the peptide takes on a short alpha-helical conformation that provides an additional binding site with the N-terminal SH3 domain. Thus, the C-terminal alpha-helical region of the p22phox peptide increases the binding affinity for the tandem SH3 domains of p47phox more than 10-fold.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16326715     DOI: 10.1074/jbc.M505193200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Phagocytosis-coupled activation of the superoxide-producing phagocyte oxidase, a member of the NADPH oxidase (nox) family.

Authors:  Reiko Minakami; Hideki Sumimotoa
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

2.  Fc gamma R-stimulated activation of the NADPH oxidase: phosphoinositide-binding protein p40phox regulates NADPH oxidase activity after enzyme assembly on the phagosome.

Authors:  Wei Tian; Xing Jun Li; Natalie D Stull; Wenyu Ming; Chang-Il Suh; Sarah A Bissonnette; Michael B Yaffe; Sergio Grinstein; Simon J Atkinson; Mary C Dinauer
Journal:  Blood       Date:  2008-08-18       Impact factor: 22.113

Review 3.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

4.  Structural, functional, and bioinformatic studies demonstrate the crucial role of an extended peptide binding site for the SH3 domain of yeast Abp1p.

Authors:  Elliott J Stollar; Bianca Garcia; P Andrew Chong; Arianna Rath; Hong Lin; Julie D Forman-Kay; Alan R Davidson
Journal:  J Biol Chem       Date:  2009-07-09       Impact factor: 5.157

5.  p47phox molecular activation for assembly of the neutrophil NADPH oxidase complex.

Authors:  Julien Marcoux; Petr Man; Isabelle Petit-Haertlein; Corinne Vivès; Eric Forest; Franck Fieschi
Journal:  J Biol Chem       Date:  2010-06-30       Impact factor: 5.157

6.  Trimer hydroxylated quinone derived from apocynin targets cysteine residues of p47phox preventing the activation of human vascular NADPH oxidase.

Authors:  Mauricio Mora-Pale; Seok Joon Kwon; Robert J Linhardt; Jonathan S Dordick
Journal:  Free Radic Biol Med       Date:  2011-12-29       Impact factor: 7.376

7.  Identification of a region in p47phox/NCF1 crucial for phagocytic NADPH oxidase (NOX2) activation.

Authors:  Outi Sareila; Noora Jaakkola; Peter Olofsson; Tiina Kelkka; Rikard Holmdahl
Journal:  J Leukoc Biol       Date:  2012-12-27       Impact factor: 4.962

Review 8.  Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.

Authors:  Grant R Drummond; Stavros Selemidis; Kathy K Griendling; Christopher G Sobey
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

9.  Proline rich polypeptide (PRP-1) increases the superoxide-producing and ferrihemoglobin reducing activities of cytochrome B(558) isoforms from human lymphosarcoma tissue cells.

Authors:  G M Simonyan; K A Galoian; R M Simonyan; M A Simonyan; A A Galoyan
Journal:  Neurochem Res       Date:  2011-01-07       Impact factor: 3.996

10.  Activation of the superoxide-producing phagocyte NADPH oxidase requires co-operation between the tandem SH3 domains of p47phox in recognition of a polyproline type II helix and an adjacent alpha-helix of p22phox.

Authors:  Ikuo Nobuhisa; Ryu Takeya; Kenji Ogura; Noriko Ueno; Daisuke Kohda; Fuyuhiko Inagaki; Hideki Sumimoto
Journal:  Biochem J       Date:  2006-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.